People - May 2004

Published: 1-May-2004


Dr David Moody has been appointed as vp commercial operations at CSS (Chemical Synthesis Services) in Northern Ireland. He has previously worked with RTZ, ICI and AstraZeneca before becoming director of new technology ventures at Avecia. Dr Moody brings to CSS extensive knowledge and expertise in the global pharmaceutical fine chemicals market.

Matthias Zachert has been named as the chief financial officer of Lanxess by the Bayer board of management and will take up his position on 1 June. He is currently group chief financial officer of Kamps, where he was involved in the realignment of the company. His appointment completes the management team of the new company, which comprises large sections of the present Bayer Chemicals and some operations of Bayer Material Science. NewCo is scheduled to be listed on the stock market under the Lanxess name by early 2005.

Dr Ellen de Brabander has been appointed new business unit director of DSM Pharma Chemicals.

US biopharmaceutical company Anadys Pharmaceuticals has hired Renee Lamb, formerly of Biogen-Idec, as senior director of regulatory affairs. Additionally, Anadys has promoted Michael Kamdar to senior vice president of corporate development and finance.

Dr Frank Malinoski has been named as the new executive vice president development and chief medical officer at Oxxon Therapeutics, a biotechnology company developing immunotherapeutics for cancer and chronic infectious diseases based on its novel proprietary PrimeBoost technology. He brings 18 years of experience in vaccine and immunotherapeutic development to Oxxon, most recently at Wyeth Vaccines, where he served in various roles including vice president of global business development, vice president of global medical affairs, and director of clinical research.

Specialist pharmaceutical packaging provider Brecon Pharmaceuticals has appointed Louise Dando as new business development manager to assist the company in its 2004 expansion programme. She joins Brecon from Alcan Packaging and is responsible for maintaining and developing the existing customer base and for implementing Brecon's new business strategy.

William Diaz has been appointed as director and general manager of Foster Wheeler USA's Puerto Rico Operations. Based in San Juan, he will develop local opportunities in pharmaceuticals and biotech.

See more

You may also like

Medical Devices

Syensqo introduces medical-grade Amodel PPA for single-use, high-temperature medical devices

Read more
A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies

Trending Articles

  1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
  2. Abselion launches AAVX and AAV9 Total Capsid Quantification Kits Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
  3. diaago and Peak Analysis & Automation partner to bring practical automation solutions to research laboratories Using diaago's customer-first approach with PAA’s decades of expertise in laboratory robotics, the collaboration promises to deliver solutions to streamline workflows, boost throughput and reduce bottlenecks
  4. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
  5. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Medical Devices

Syensqo introduces medical-grade Amodel PPA for single-use, high-temperature medical devices

A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies
Manufacturing

Sapio Sciences introduces world’s first 3rd-generation ELN

Sapio ELaiN is an AI-powered lab notebook designed to act as a scientific collaborator
Manufacturing

Signal Group launches MCERTS approved VOC emissions monitor

New SOLAR CEMNEX analyser offers advanced compliance and connectivity features
Research & Development

Genoskin raises $8.7m in its first funding round to advance its ethical, human-based alternatives to animal testing

The financing will drive Genoskin’s next phase of growth, with a view to scaling up operations in both the US and France
You need to be a subscriber to read this article.
Click here to find out more.
Packaging

Cloud labelling and serialisation: the new frontline of traceability in drug delivery

As drug delivery evolves to accommodate a new wave of data-driven innovation, the need for traceability and compliance throughout the supply chain is paramount. Innovative cloud-based solutions enable pharmaceutical companies to navigate these demands with confidence
Manufacturing

Sharp boosts autoinjector and pen assembly line capability with $20m investment in Pennsylvania facility

The money will boost its autoinjector and pen assembly, labelling and packaging lines across various therapeutic areas at its facility in Macungie, meeting the rising demand for injectables
Manufacturing

L.B. Bohle to showcase machines for OSD, food and nutraceuticals at PACK EXPO 2025

Company to present advanced blending, particle sizing and coating technologies at Las Vegas event
Subscribe now